|
SIPA1L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.959600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.261750E-02 |
| Normal-vs-Stage2 |
1.080840E-01 |
| Normal-vs-Stage3 |
3.157600E-01 |
| Normal-vs-Stage4 |
1.412090E-02 |
| Stage1-vs-Stage2 |
7.234000E-01 |
| Stage1-vs-Stage3 |
6.739600E-01 |
| Stage1-vs-Stage4 |
4.919200E-01 |
| Stage2-vs-Stage3 |
5.964800E-01 |
| Stage2-vs-Stage4 |
7.211000E-01 |
| Stage3-vs-Stage4 |
4.359200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.132100E-02 |
| Normal-vs-AfricanAmerican |
1.460790E-03 |
| Normal-vs-Asian |
2.240700E-03 |
| Caucasian-vs-AfricanAmerican |
7.412300E-02 |
| Caucasian-vs-Asian |
1.755870E-02 |
| AfricanAmerican-vs-Asian |
4.086200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.187860E-02 |
| Normal-vs-Female |
4.674400E-01 |
| Male-vs-Female |
2.078800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.684800E-03 |
| Normal-vs-Extreme_Weight |
2.588300E-02 |
| Normal-vs-Obese |
6.409000E-01 |
| Normal-vs-Extreme_Obese |
3.475800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.762800E-01 |
| Normal_Weight-vs-Obese |
6.935700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.320400E-01 |
| Extreme_Weight-vs-Obese |
1.607380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.907800E-01 |
| Obese-vs-Extreme_Obese |
5.151000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.985000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.652200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.476990E-03 |
| Normal-vs-Age(81-100Yrs) |
1.511950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.564800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.515500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.854000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.212100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.479400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.750400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.060800E-01 |
| Normal-VS-Type2 PRCC |
1.382310E-03 |
| Normal-VS-KIRP CIMP |
8.306800E-01 |
| Normal-VS-Unclassified PRCC |
9.690100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.778300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.592200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.195800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.287600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.795200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.585600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.344800E-03 |
| Normal-vs-N1 |
4.013600E-01 |
| Normal-vs-N2 |
4.913800E-01 |
| N0-vs-N1 |
1.778210E-01 |
| N0-vs-N2 |
5.402600E-01 |
| N1-vs-N2 |
9.541600E-01 |
|
|
